0001567619-21-009092.txt : 20210505
0001567619-21-009092.hdr.sgml : 20210505
20210505160202
ACCESSION NUMBER: 0001567619-21-009092
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210503
FILED AS OF DATE: 20210505
DATE AS OF CHANGE: 20210505
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GHALIE RICHARD G
CENTRAL INDEX KEY: 0001156208
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50484
FILM NUMBER: 21893110
MAIL ADDRESS:
STREET 1: C/O FAVRILLE, INC
STREET 2: 10445 PACIFIC CENTER COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MEI Pharma, Inc.
CENTRAL INDEX KEY: 0001262104
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 510407811
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 11455 EL CAMINO REAL
STREET 2: SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-369-7100
MAIL ADDRESS:
STREET 1: 11455 EL CAMINO REAL
STREET 2: SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: MARSHALL EDWARDS INC
DATE OF NAME CHANGE: 20030902
4
1
doc1.xml
FORM 4
X0306
4
2021-05-03
0
0001262104
MEI Pharma, Inc.
MEIP
0001156208
GHALIE RICHARD G
C/O MEI PHARMA, INC.,
11455 EL CAMINO REAL, SUITE 250
SAN DIEGO
CA
92130
0
1
0
0
Chief Medical Officer
Stock Option (Right to Buy)
3.55
2021-05-03
4
A
0
75000
0
A
2031-05-03
Common Stock
75000
75000
D
Stock Option (Right to Buy)
1.21
2026-03-07
Common Stock
130000
130000
D
Stock Option (Right to Buy)
1.38
2026-07-14
Common Stock
25000
155000
D
Stock Option (Right to Buy)
2.88
2027-07-07
Common Stock
65000
220000
D
Stock Option (Right to Buy)
4.28
2028-07-12
Common Stock
130000
350000
D
Stock Option (Right to Buy)
2.52
2029-07-01
Common Stock
150000
500000
D
Stock Option (Right to Buy)
3.49
2030-07-02
Common Stock
150000
650000
D
1/4th of shares vest one-year from 5/03/2021, with the remaining balance of shares vesting in 36 equal amounts over three years.
All options are currently exercisable.
1/4th of shares vest one-year from July 7, 2017, with the remaining balance of shares vesting in 36 equal amounts over three years.
1/4th of shares vest one-year from July 12, 2018, with the remaining balance of shares vesting in 36 equal amounts over three years.
1/4th of shares vest one-year from July 1, 2019, with the remaining balance of shares vesting in 36 equal amounts over three years.
1/4th of shares vest one-year from July 2, 2020, with the remaining balance of shares vesting in 36 equal amounts over three years.
/s/ Richard Ghalie MD
2021-05-05